SciELO - Scientific Electronic Library Online

 
vol.25 issue3Sweating in patients with chronic Chagas' diseaseFocused ultrasound: a new weapon for stereotaxic surgery author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Abstract

ARMBRUST-FIGUEIREDO, Jorge. Methysergide in the treatment of temporal lobe epilepsy. Arq. Neuro-Psiquiatr. [online]. 1967, vol.25, n.3, pp.221-226. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X1967000300007.

Methysergide (1-methyl-lysergic acid butanolamide) was used experimentally in 78 patients with psychomotor epilepsy and with focal abnormal activity (sharp waves) in one of the temporal lobes, in the EEG. The usual dosage of methysergide was 2 to 6 mg daily (only 36 patients received more than 2 mg daily) and every patient received fenobarbital 0.1 g daily also. Out of the 78 patients, 59 responded well to the treatment; 47 were free of seizures and in 12 there was decrease in frequency and severity of seizures. Psychic symptoms also decreased with the use of methysergide. The EEG was improved in 27 per cent of patients and became normal in 37 per cent, after twelve months of treatment. Slight side effects were reported by 39 pacients but they disappeared in a few days.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf epdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License